Antimicrobials from an Epigenetics Based Fungal Metabolite Screening Program

Novel antimicrobial compounds against drug targets such as Eskape pathogens, Leishmania donovani, Mycobacterium tuberculosis, Clostridium difficile, Naegleria fowleri, and cancer are presented herein.

Patents:
US 10,144,719 issued 2018-12-04   [MORE INFO]

Type of Offer: Licensing



« More Biology Patents

Share on      


CrowdSell Your Patent